MEDI-LASE
Multifunctional MEdical DIagnostic LASEr System
| Coordinatore | UNIVERSITY OF DUNDEE
Organization address
address: Nethergate contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 1˙630˙569 € |
| EC contributo | 1˙630˙569 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2009-IAPP |
| Funding Scheme | MC-IAPP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-05-01 - 2014-04-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITY OF DUNDEE
Organization address
address: Nethergate contact info |
UK (DUNDEE) | coordinator | 785˙347.00 |
| 2 |
SCIENTIFIC-PRODUCTION ENTERPRISE LAZMA LTD
Organization address
address: KUUSINENA 11 33 contact info |
RU (MOSKVA) | participant | 450˙956.00 |
| 3 |
Askion GmbH
Organization address
address: GEWERBEPARK KEPLERSTRASSE 17-19 contact info |
DE (GERA) | participant | 394˙266.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'MEDI-LASE proposes to perform a joint research programme capitalising on the knowledge and expertise of the partners through exchanges of researchers and transfers of knowledge between research centres at the University of Dundee, Laser Physics and the Institute of Medical Science and Technology and two SME companies with expertise in different aspects of photonics based diagnosis, a manufacturer and developer of state-of-the-art medical diagnostics equipment ASKION GMbH and a Russian developer of integrated diagnostic laser systems LAZMA. The aims are to overcome scientific and technical challenges to the realisation and adoption of a unique multifunctional non-invasive laser diagnostic system. Specifically, new and novel laser sources will be developed and validation of the spectroscopy and complex algorithms required to provide relevant and reliable diagnosis of specific biological conditions. The work will comprise experimental research in the optical analysis of blood and tissue to direct the exploitation of the developed system. The project will draw on technology and expertise from all three partners while training 4 early stage researchers and providing career development opportunities for 4 recruited experienced researchers. Many opportunities for further research collaborations exist between the partners and it is anticipated that MEDI-LASE will facilitate the development of relations to catalyse ongoing long-term collaborations.'